657 results on '"Distler J"'
Search Results
2. Healthcare utilization and unmet needs of patients with antisynthetase syndrome: An international patient survey
3. OP0319 G PROTEIN-COUPLED RECEPTOR KINASE 5 REGULATES FIBROBLAST ACTIVATION AND FIBROTIC TISSUE REMODELLING IN SYSTEMIC SCLEROSIS
4. AB1144 THE ROLE OF SYSTEMIC S100A4 LEVELS IN SCLERODERMA AS A PREDICTOR OF TREATMENT RESPONSE AND EARLY PROGRESSION
5. OP0166 SKIN RETICULARIZATION IN SYSTEMIC SCLEROSIS - POTENTIAL MEDIATORS
6. POS0142 A CLINICAL AND SCIENTIFIC RESEARCH PLATFORM FOR SECONDARY USE OF REAL WORLD DATA WITH AI METHODS – CONSENT RATE ANALYSIS FROM THE INFORMED BROAD CONSENT
7. POS0829 LONG-TERM PROGNOSTIC VALUE OF INNATE LYMPHOID CELLS IN SYSTEMIC SCLEROSIS: A COMPREHENSIVE 5-YEAR ANALYSIS
8. POS0025 ACTIVATION OF NOTCH1 SIGNALING IN FIBROBLASTS IS SUFFICIENT TO INDUCE FIBROSIS AND ACTIVATES A NETWORK OF PROFIBROTIC SIGNALING CASCADES
9. POS0558 INTERFERING WITH THE COLLABORATIVE DNA BINDING OF EN1 AMELIORATES FIBROTIC TISSUE REMODELING IN SYSTEMIC SCLEROSIS
10. OP0320 EFFICACY OF CD19-TARGETING CAR T CELL TREATMENT IN PATIENTS WITH DIFFUSE SYSTEMIC SCLEROSIS (dSSc) – AN OPEN LABEL, SINGLE-CENTER PILOT STUDY
11. AB1146 ALTERNATIVE SPLICING IDENTIFICATION IN SYSTEMIC SCLEROSIS AND THEIR ROLES IN SKIN FIBROSIS
12. AB1153 IDENTIFYING THE INVOLVEMENT OF ADROPIN/ENHO IN SYSTEMIC SCLEROSIS (SSc) THROUGH MACHINE LEARNING AND MULTI-MODEL VALIDATION
13. OP0178 IMAGING MASS CYTOMETRY-BASED CHARACTERIZATION OF FIBROBLASTS SUBSETS, THEIR NETWORKS AND SPATIAL MICROENVIRONMENT IN SYSTEMIC SCLEROSIS
14. OP0144 MULTIPLE SPATIAL PROTEOMICS TO DEFINE ENDOTHELIAL CELL PHENOTYPES AND ALTERATIONS OF THE VASCULAR NICHE IN SSc
15. AB1141 THERAPEUTIC POTENTIAL OF INHIBITION OF JAK1 AND 2 BY RUXOLITINIB, OF ROCK2 BY BELUMOSUDIL, AND OF BTK BY IBRUTINIB IN SYSTEMIC SCLEROSIS
16. POS0007 THE NUCLEAR RECEPTOR DAX1 REGULATES WNT/Β-CATENIN SIGNALING TO PROMOTE FIBROBLAST ACTIVATION AND SKIN FIBROSIS IN SYSTEMIC SCLEROSIS
17. Blocking Signaling Pathways Like Notch and Hedgehog Reduces Chronic Rejection in a Murine Aortic Transplant Model
18. Blocking Signaling Pathways Like Notch and Hedgehog Reduces Neointima Formation in a Murine Aortic Transplant Model
19. Versorgungsrealität der stationären vasoaktiven Therapie mit Prostazyklinderivaten bei Patienten mit akralen Durchblutungsstörungen bei systemischer Sklerose in Deutschland
20. Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research
21. Autologe hämatopoetische Stammzelltransplantation bei systemischer Sklerose: Positionspapier des Arbeitskreises Stammzelltherapie der Deutschen Gesellschaft für Rheumatologie
22. Therapie der systemischen Sklerose-assoziierten interstitiellen Lungenerkrankung
23. Non-birational twisted derived equivalences in abelian GLSMs
24. Heterotic compactifications with principal bundles for general groups and general levels
25. POS0620 BI 685509: A POTENT ACTIVATOR OF SOLUBLE GUANYLATE CYCLASE (SGC) AS A NOVEL TREATMENT OF VASCULOPATHY AND FIBROSIS IN SYSTEMIC SCLEROSIS (SSc)
26. POS0148 STIFFNESS INDUCED PROGRESSION OF FIBROSIS BY SORBIN AND SH3 DOMAIN-CONTAINING PROTEIN2 IN SYSTEMIC SCLEROSIS
27. OP0238 IMMUNOSUPPRESSION WITH TARGETED DMARDS REDUCES MORBIDITY AND MORTALITY IN PRE-CAPILLARY PULMONARY HYPERTENSION ASSOCIATED WITH SYSTEMIC SCLEROSIS: A EUSTAR ANALYSIS
28. OP0106 SYNOVIAL IMPRINTING OF SKIN-DERIVED IMMUNE CELLS INITIATES SPREADING OF INFLAMMATION FROM SKIN TO JOINT IN PSORIATIC ARTHRITIS
29. POS0377 ACCURACY OF AN AI-BASED SYMPTOM CHECKER AND AN ONLINE SELF-REFERRAL TOOL IN RHEUMATOLOGY: RESULTS FROM A MULTICENTER RANDOMIZED CONTROLLED TRIAL
30. POS1255 CLINICAL SIGNIFICANCE OF THE ANTI-NUCLEOLAR ORGANIZER REGION 90 ANTIBODIES (NOR90) IN SYSTEMIC SCLEROSIS: A EUROPEAN SCLERODERMA TRIALS AND RESEARCH (EUSTAR) ANALYSIS
31. Resolving Singularities in (0,2) Models
32. On the Instanton Contributions to the Masses and Couplings of $E_6$ Singlets
33. Neue molekulare Mechanismen in der Pathophysiologie rheumatologischer Erkrankungen
34. (0,2) Landau-Ginzburg Theory
35. Osteoimmunologie – IMMUNOBONE: Regulation des Knochens durch Entzündung
36. Notes on N=2 $\sigma$-models$
37. A note on the 3D Ising model as a string theory
38. World-Sheet Supersymmetry Without Contact Terms
39. INREAL – Nintedanib for changes in dyspnea and cough in chronic PF-ILD patients in everyday clinical practice: a real-world evaluation*
40. Digitale Ulzerationen bei systemischer Sklerose: Eine Versorgungsforschungsstudie über den Einsatz von Bosentan und anderen vasoaktiven Therapien
41. Evaluation of Fluence- and Segment Optimisation Parameter for IMRT of the Anal Cancer
42. Late Skin Fibrosis in Systemic Sclerosis: A Study from the EUSTAR Cohort
43. Persistent inflammation in systemic sclerosis is strongly associated with mortality: a EUSTAR database analysis
44. Stress system dysregulation in pediatric generalized anxiety disorder associated with comorbid depression
45. POS0140 PREDICTING OUTCOMES IN SYSTEMIC SCLEROSIS: STRATIFICATION BY AUTO-ANTIBODIES OUTPERFORMS CUTANEOUS SUBSETTING IN THE EUSTAR COHORT
46. POS0893 FACTORS TO CONSIDER FOR MEASURING THE EFFECT OF LUNG FUNCTION ON PATIENT REPORTED OUTCOMES IN SYSTEMIC SCLEROSIS PATIENTS: ANALYSIS OF THE EUSTAR DATABASE.
47. POS0864 ASSESSMENT OF SYSTEMIC SCLEROSIS RELATED MYOCARDIAL FIBROSIS BY 68Ga-FAPI-04 PET/CT
48. POS0874 GLUCOCORTICOIDS PRESCRIBING PRACTICES IN SYSTEMIC SCLEROSIS: AN ANALYSIS OF THE EUSTAR DATABASE.
49. POS0385 “EFFECTIVE LUNG AGE” IN SUBJECTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSc-ILD) IN THE SENSCIS TRIAL
50. POS0477 ATTENUATION OF FIBROBLAST ACTIVATION AND FIBROSIS BY ADROPIN IN A HEDGEHOG-DEPENDENT MANNER
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.